中國先鋒醫藥(01345.HK)擬探尋及開發環保新業務
格隆匯2月3日丨中國先鋒醫藥(01345.HK)公告,於中國(就本公告而言,不包括香港特別行政區、澳門特別行政區及台灣地區)的環保行業探尋及開發機遇。
截至本公告日期,集團正在開發其有關潛在新業務的業務策略,惟並未就潛在新業務對任何併購制定具體計劃或物色具體目標,亦並未與任何合營企業夥伴或商業夥伴達成任何協議。
集團一直積極探索機會以物色具未來發展及進一步擴展增長潛力的市場,為股東創造價值及提升回報。鑑於中國的發展路向及加強對環保的相應需求,潛在新業務實屬值得探索的合適範疇。儘管集團計劃對潛在新業務作出探索,惟於中國為進口醫藥產品及醫療器械提供綜合性營銷、推廣及渠道管理服務的現有主要業務將繼續為集團的核心業務。
董事會預期,倘潛在新業務落實,則可使集團拓闊業務組合及使其其收入來源多元化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.